A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Dren Bio
Dren Bio
Hangzhou Hanx Biopharmaceuticals, Ltd.
Diakonos Oncology Corporation
Merck Sharp & Dohme LLC
University of Wisconsin, Madison
National Cancer Institute (NCI)
Immatics US, Inc.
Bristol-Myers Squibb
Toray Industries, Inc
National Cancer Institute (NCI)
Johns Hopkins University
7 Hills Pharma, LLC
University of Pittsburgh
Genmab
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
Aulos Bioscience, Inc.
Ipsen
H. Lee Moffitt Cancer Center and Research Institute
Melanoma and Skin Cancer Trials Limited
Obsidian Therapeutics, Inc.
Georgiamune Inc
University of Wisconsin, Madison
BeOne Medicines
Hoffmann-La Roche
M.D. Anderson Cancer Center
Filamon LTD
AstraZeneca
Merck Sharp & Dohme LLC
Mayo Clinic
BioNTech SE
Aminex Therapeutics, Inc.
Perspective Therapeutics
University of Southern California
Neonc Technologies, Inc.
Hummingbird Bioscience
Replimune Inc.
Bristol-Myers Squibb
Children's Oncology Group
Ossium Health, Inc.
Duke University
Arvinas Inc.
BioInvent International AB
M.D. Anderson Cancer Center
Essen Biotech
Essen Biotech
Sapience Therapeutics
Ariceum Therapeutics GmbH